Authors: Ghielmini, M Schmitz, SFH Burki, K Pichert, G Betticher, DC Stupp, R Wernli, M Lohri, A Schmitter, D Bertoni, F Cerny, T

Citation: M. Ghielmini et al., The effect of Rituximab on patients with follicular and mantle-cell lymphoma, ANN ONCOL, 11, 2000, pp. 123-126

Authors: Biedermann, B Landmann, C Kann, R Passweg, J Soler, M Lohri, A Rochlitz, C Herrmann, R Pless, M

Citation: B. Biedermann et al., Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer, RADIOTH ONC, 56(2), 2000, pp. 169-173

Authors: Rochlitz, C Lohri, A Bacchi, M Schmidt, M Nagel, S Fopp, M Fey, MF Herrmann, R Neubauer, A

Citation: C. Rochlitz et al., Axl expression is associated with adverse prognosis and with expression ofBcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK), LEUKEMIA, 13(9), 1999, pp. 1352-1358